 36 PM / Updated 5 minutes ago BRIEF-Sucampo Pharmaceuticals Received Notification From FDA That It Has Extended PDUFA Goal Date By 3 Months Reuters Staff 1 Min Read 
Jan 2 (Reuters) - Sucampo Pharmaceuticals Inc: 
* SUCAMPO PHARMACEUTICALS - ON DEC 28, RECEIVED NOTIFICATION FROM U.S. FDA THAT IT HAS EXTENDED PDUFA GOAL DATE BY 3 MONTHS FOR SNDA FOR LUBIPROSTONE 
* SUCAMPO PHARMACEUTICALS - EXTENDED USER FEE GOAL DATE FOR THE SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR LUBIPROSTONE IS APRIL 28, 2018- SEC FILING Source text :[ bit.ly/2Ctygjm ] Further company coverage: